Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
    • Transkriptioner
  • InderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Bolag under bevakning
    • Teamet
Regulatoriskt pressmeddelande

Sprint Bioscience appoints Jessica Martinsson as acting CEO after CEO Anders Åberg announces his resignation

Sprint Bioscience
Läs börsmeddelandet

Anders Åberg co-founded Sprint Bioscience and during his ten years as CEO has led the work of building an effective research and development organization that has been able to attract a number of international partners. In recent years, the company has established three license agreements with global pharmaceutical companies.

"When we founded Sprint Bioscience, we had a clear vision of how, through a combination of efficient process development and pioneering technology, we could generate drug candidates for global pharmaceutical companies. The fact that we have been able to build up the company in such a short time and to out-license three projects shows that we can create long-term values for our customers and shareholders. After these 10 years as CEO, it is now time for me to have time for other things," says Anders Åberg, CEO of Sprint Bioscience.[Jessica Martinsson]

The Board of Directors of Sprint Bioscience has appointed Jessica Martinsson as acting CEO. Jessica has held the position of operational manager and is co-founder of the company.

"We thank Anders Åberg for all the fantastic work that has led to Sprint Bioscience becoming the high-quality company it is today. Jessica Martinsson has also played a significant role in the company's success since its inception, and she will now, together with a very competent management team, take responsibility for its continued development. The Board has initiated a structured process to appoint a permanent CEO," says Rune Nordlander, Chairman of Sprint Bioscience.

Anders Åberg leaves the position as CEO on June 11 and Jessica Martinsson will take up the position of acting CEO at that time. Anders Åberg retains his shareholding and will remains as senior adviser to the company but will not have an operational role.

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.